Historical evolution in the understanding of Stargardt macular dystrophy

Ophthalmic Genetics

Volumn 31, Issue 4, 2010, Pages 183-189

  Fishman, Gerald Allen ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

ABCA4 mutations; Historical perspective; Mouse models; Stargardt disease

Indexed keywords

ABC TRANSPORTER; ABCA4 PROTEIN; LIPOFUSCIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; CHOROID; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTRORETINOGRAPHY; EVOLUTION; EYE FUNDUS FLAVIMACULATUS; GENE LOCATION; GENE MUTATION; GENETIC DISORDER; GENETICS; HISTOPATHOLOGY; HUMAN; OPHTHALMOLOGY; PATHOGENESIS; PHENOTYPE; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PUBLICATION; RETINA MACULOPATHY; RETINA NEUROEPITHELIAL LAYER; REVIEW; STARGARDT MACULAR DYSTROPHY; TREATMENT INDICATION; VISUAL ADAPTATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CORNEAL DYSTROPHIES, HEREDITARY; DISEASE MODELS, ANIMAL; GERMANY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MUTATION;

EID: 78649256921     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2010.499887     Document Type: Review

References (32)

1. Stargardt K. Über familiäre, progressive degeneration in der maculagegend des auges. Albrecht von Graefes Arch Klin Ophthalmology, 1909;71:534-550.
2. Blacharski P. Fundus favimaculatus. In: Newsome DA, ed. Retinal Dystrophies and Degenerations. New York: Raven Press;1988:135-159.
3. Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology, 2003;110:1151-1158.
4. Francheschetti A, François J. Fundus favimaculatus. Archives of Ophthalmology (Paris), 1965;25:505-530.
5. Francheschetti A. A special form of tapetoretinal degeneration: fundus favimaculatus. Transactions of the American Academy of Ophthmology & Otolaryngology, 1965;69:1048-1053.
6. François P, Turut P, Puech B, Hache J-C. Maladie de Star-gardt et fundus favimaculatus. Archives of Ophthalmology (Paris),1975;35:817-846.
7. Schlossman A, Franceschetti A. A. Franceschetti\great ophthalmologist and humanitarian. Survey of Ophthalmology, 2001;45:525-530.
8. Krill AE, Klien BA. Flecked retina syndrome. Archives of Ophthalmology, 1965; 74:496-508.
9. Klien BA, Krill AE. Fundus favimaculatus: clinical, functional, and histopathologic observations. American Journal of Ophthalmology, 1967;64:3-23.
10. Fishman GA. Fundus favimaculatus: a clinical classifca-tion. Archives of Ophthalmology, 1976; 94:2061-2067.
11. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AE. Phenotypic subtypes of Stargardt macular dystrophy\fundus favi-maculatus. Archives of Ophthalmology, 2001;119:359-369.
12. Bonnin MP. Le signe du silence choroïdien dans les dégenérescences tapeto-rétiniennes centrales examinées sous fuorescéine. Bulletin of the Society of Ophthalmology Fr, 1971;71:348-351.
13. Fish G, Grey R, Sehmi KS, Bird AC. The dark choroid in posterior retinal dystrophies. British Journal of Ophthalmology, 1981;65:359-363.
14. Anmarkrud N. Fundus fuorescein angiography in fundus favimaculatus and Stargardts disease. Acta Ophthlamo-logica, 1979;57:172-182.
15. Ernest JT, Krill AE. Fluorescein studies in fundus favimac-ulatus and drusen. American Journal of Ophthalmology, 1966;62:1-6.
16. Eagle RC, Lucier AC, Bernardino VB, et al. Retinal pigment epithelial abnormalities in fundus favimaculatus: a light and electron microscopic study. Ophthalmology, 1980;87:1189-1200.
17. Delori FC, Staurenghi G, Arend O, Dorey CK, et al. In vivo measurement of lipofuscin in Stargardt disease-fundus fa-vimaculatus. Investigative Ophthalmology and Visual Science, 1995;36:2327-2331.
18. von Rückmann A, Fitzke FW, Bird AC. In vivo fundus auto-fuorescence in macular dystrophies. Archives of Ophthalmology, 1997:115:609-615.
19. Gerber S, Rozet J-M, Bonneau D, Souied E, et al. A gene for late-onset fundus favimaculatus with macular dystrophy maps to chromosome 1p13. American Journal of Human Genetics, 1995;56:396-399.
20. Allikmets R, Singh N, Sun H, Shroyer NF, et al. A photore-ceptor cell-specifc ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nature Genetics, 1997;15:236-246.
21. Cremers FPM, van de Pol DJR, van Driel M, et al. Auto-somal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Human Molecular Genetics, 1998;7: 355-362.
22. Birch DG, Peters AY, Locke KL, et al. Visual function in patients with cone-rod dystrophy (CRD) associated with mutations in the ABCA4 (ABCR) gene. Experiments in Eye Research, 2001;73:877-886.
23. Fishman GA, Stone EM, Eliason DA et al. ABCA4 gene sequence variations in patients with autosomal recessive cone-rod dystrophy. Archives of Ophthalmology, 2003;121:851-855.
24. Klevering BJ, van Driel M, van de Pol JR, et al. Phenotypic variations in a family with retinal dystrophy as a result of different mutations in the ABCR gene. British Journal of Ophthalmology, 1999;83:914-918.
25. Martinez-Mir A, Paloma E, Allikmets R, et al. Retinitis pig-mentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nature Genetics, 1998;18:11-12.27.
26. Sun H, Nathans J. Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments. Nature Genetics, 1997;17:15-16.
27. Molday LL, Rabin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nature Genetics, 2000;25:257-258.
28. Weng J, Mata NL, Azarian SM, Tzekov RT, et al. Insights into the function of rim protein in photoreceptors and etiology of Stargardt disease from the phenotype in abcr knockout mice. Cell, 1999;98:13-23.
29. Radu RA, Mata NL, Nusinowitz S, Liu X, et al. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proceedings of the National Academy of Science USA, 2003;100:4742-4747.
30. Radu RA, Mata NL, Baga A, Travis GH, et al. Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration. Proceedings of the National Academy of Science USA, 2004;101: 5928-5933.
31. Radu RA, Han Y, Bui TV, et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fuorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Investigative Ophthalmology and Visual Science, 2005;46:4393-4401.
32. Radu RA, Yuan Q, Hu J, Peng JH, et al. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Investigative Ophthalmology and Visual Science, 2008;49:3821-3829.